The valsartan was supplied by Zhejiang Huahai Pharmaceuticals. Keep taking your medicine if it contains valsartan, unless you have been told to stop by your doctor or pharmacist. If you are taking any medication containing valsartan, speak to your pharmacist who can tell you if your medicine is being recalled. If you have been using an affected pro
A double-blind, prospective, randomized clinical study found that wounds treated with Kerecis Omega3 Wound healed significantly faster than wounds treated with EpiFix from MiMedx . The Kerecis product is made from intact fish skin; EpiFix is made from human amnion membrane. Kerecis will unveil detailed results of the study at the annual s
July 09 AUGUSTA, Maine Republicans in the Maine House of Representatives on Monday upheld Gov. The bill vetoed this year by LePage would have put up to $54.7 million toward funding startup costs for expansion, with $31.2 million coming from the state budget and a possible $23.5 million from the Fund for a Healthy Maine, which is largely funded
The latest report on the global Electronic Health Records Software market presents answers to crucial questions that are important to comprehend developments in the said A holistic and detailed overview of the global Electronic Health Records Software market that includes information derived from utilizing various quantitative and qualitative...
The U.S. Department of Health and Human Services issued the following remarks by Secretary Alex M. Azar II at the 340 B Coalition summer meeting:. "Thank you for that introduction, Maureen, and thank you to all of the members of the 340 B Coalition for welcoming me here today. "All of you are here because you share an interest in a program that h
The prices of drugs in the US market, a major export destination for Indian companies, are eroding and so have affected manufacturers here. According to the data available with the industry, price erosion in Jan- Mar 2018 was around 8-10 percent and this is trend will continue in 2018-2019 also. The overall sales in the US dropped, for Sun Pharmace
Albany, NY 07/09/2018 This report studies the global Pacemakers and Cardiac Resynchronization Therapy Devices market status and forecast, categorizes the global Pacemakers and Cardiac Resynchronization Therapy Devices market size by key players, type, application, and region. This report focuses on the top players in North America, Europe, Ch
"I would urge you to a hold a hearing soon on the anti-competitive practices of pharmaceutical companies and the abuses of FDA' s regulatory programs to delay generic competition," Pallone wrote to Walden and Burgess. Food and Drug Administration Commissioner Scott Gottlieb has been outspoken about pharmaceutical manufacturers' "gaming" of regulato
Adagene, Inc., an innovative antibody engineering and discovery company, has received notification from the FDA to proceed on its Investigational New Drug application to study its lead product in patients with advanced solid tumors and non-Hodgkin lymphoma. Adagene will investigate the safety and efficacy of ADG-106 therapy as a single agent acro
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Zika Virus Vaccines in these regions, from 2012 to 2023, covering North America Europe Asia-Pacific South America Middle East and Africa. Global Zika Virus Vaccines market competition by top manufacturers, with p
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Su, Zhishen, filed on July 24, 2017, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Purdue Pharma L.P.. The following quote w
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BUCK, RACHAEL; DUSKA-MCEWEN, GERALYN O.; SCHALLER, JOSEPH P., filed on February 9, 2018, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Ellingson, Benjamin; Harris, Robert, filed on May 27, 2016, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compa
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors YU, Luping; WANG, Wencheng, filed on June 3, 2016, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or ins
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors ZACHARIE, Boulos; PENNEY, Christopher; GAGNON, Lyne; BIENVENU, Jean- Francois; PERRON, Valerie; GROUIX, Brigitte, filed on February 7, 2018, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., b
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors URMAN, Noa; BOMZON, Zeev, filed on December 13, 2017, was made available online on June 21, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Novocure Limited. See,
Aurora Spine Corporation announced today the 100 th surgical implantation of the company's ZIP ULTRA minimally invasive interspinous device in Canada. These surgeries are part of Aurora Spine's continuing efforts to expand the use of the Company s ZIP MIS Fusion System in North America.. "We are very excited to continue offering our ZIP
Aside from the companies highlighted on our weekly top NASDAQ biotech stocks list, Elite Pharmaceuticals received US Food and Drug Administration approval for generic percocet tablets, while Sorrento Therapeutics acquired the Sofusa lymphatic delivery technology platform from Kimberly-Clark. Later in the week Bristol-Myers Squibb received...
Cambridge, UK and Indianapolis, US- 9 July 2018: Acacia Pharma Group plc, provides an unaudited operating update for the first half 2018. Dr Julian Gilbert, CEO of Acacia Pharma, commented: "The Group has made important progress during the first half 2018 preparing for the launch, if approved, of BARHEMSYS (TM) for the treatment and prevention of p
Actinium Pharmaceuticals, Inc., provided a reminder that it will host a webcast on July 10, 2018 at 8:00 AM ET. Joseph Jurcic, Director of Hematologic Malignancies; Professor of Medicine at Columbia University Medical Center and Dr. Mark Berger, Chief Medical Officer and Sandesh Seth, Chairman and CEO of Actinium Pharmaceuticals, Inc. will lead t
Advicenne, a specialist pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announces preliminary results of the Phase III Extension Study with ADV7103 in Distal Renal Tubular Acidosis. Dr Luc Andre Granier, co-founder and CEO of Advicenne, says:' We are..
Aeromics, Inc., a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema for people affected by disabling and life-threatening severe ischemic stroke, announced today the initiation of a Phase 1 clinical trial in healthy volunteers of its first-in-class drug candidate, AER-271.. The clinical study will include
By a News Reporter-Staff News Editor at Pharma Business Week AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase II clinical trial investigating the Company's ROOT OF CANCER technology in patients wi
Detox Centers Los Angeles provides effective drug outpatient treatment programs that produce great results. Addiction is a chronic disease that affects the lives of millions of people. If you are struggling with drugs, Los Angeles drug outpatient treatment could be your path back to health.
Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria PNH in the U.S.. By a News Reporter-Staff News Editor at Pharma Business Week Alexion Pharmaceuticals, Inc. announced the submission of a Biologics License Application to the U.S. Food and Drug Administrati